Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
20 Dicembre 2024 - 10:59PM
Edgar (US Regulatory)
EXHIBIT 99.1
JOINT FILING AGREEMENT
We, the undersigned, hereby express our agreement that the Schedule 13G (or any amendments thereto) relating to the Common Stock of Palvella Therapeutics, Inc. is filed on behalf of each of us.
Dated: December 20, 2024
Samsara BioCapital, L.P.
By:
Samsara BioCapital GP, LLC
its
General Partner
By:
/s/ Srinivas Akkaraju
Name: Srinivas Akkaraju
Title: Managing Member
Samsara BioCapital GP, LLC
By:
/s/ Srinivas Akkaraju
Name: Srinivas Akkaraju
Title: Managing Member
/s/ Srinivas Akkaraju
Srinivas Akkaraju
Grafico Azioni Palvella Therapeutics (NASDAQ:PVLA)
Storico
Da Gen 2025 a Feb 2025
Grafico Azioni Palvella Therapeutics (NASDAQ:PVLA)
Storico
Da Feb 2024 a Feb 2025